Skip to content

Impacts of the Letter of Condolence to the Bereaved Families Experience After a Death in ICU - Study Famirea 22

Impacts of the Letter of Condolence to the Bereaved Families Experience After a Death in ICU - Study Famirea 22

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02325297
Acronym
Famirea 22
Enrollment
242
Registered
2014-12-24
Start date
2014-12-31
Completion date
2016-06-30
Last updated
2016-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Death, Mourning

Keywords

Intensive care unit

Brief summary

After the death of a patient in the hyper-technical context of intensive care, his relatives are particularly vulnerable and often exhibit symptoms of anxiety, depression, post traumatic stress and complicated grief. The first results of a qualitative study Famiréa current (CAESAR) support the idea that the bereaved relatives suffer from persistent misunderstandings and a feeling of abandonment of the resuscitation team. Many families suggest the need for contact with the team after the patient's death. The letter of condolence received by some families allowed them to feel recognized in their pain resuscitation teams. This has led us to ask the question of post-death monitoring and interest to send to bereaved relatives a letter of condolence, as recommended by the American consensus conference in 2004 on good palliative care. This strategy would allow the recognition of both close to the pain but also the strong bond that united the resuscitation team. The hypothesis of the study is that the post-death followed in the form of a letter of condolence sent by the intensive care physician who was in charge of the patient, could reduce the risk of having symptoms of anxiety / depression and post-traumatic stress and reduce the rate of complicated grief. Famirea 22 is randomized clinical trial aimin to compare two bereaved groups: one group who did not receive a letter of condolence and a group that received a letter of condolence 15 days after the death.

Interventions

OTHERLetter of condolence

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* death of a relative patient in intensive care whose relatives were interviewed at least once by resuscitation team * death of an adult relative patient * ICU stay of the relative patient more than 2 days

Exclusion criteria

* death of a pregnant woman * opposition to the use of its data by the patient * relative does not speak French * refusal of the relative

Design outcomes

Primary

MeasureTime frame
HADS (Hospital Anxiety and Depression Scale)1 month

Secondary

MeasureTime frameDescription
Caesar scale1 montha questionnaire describing ICU end-of-life practices and satisfaction with the patient's care, communication, and symptom management during the dying process.
IES-R (Impact of Event Scale, Revised)6 months
ICG (Inventory of Complicated grief)6 months
HADS (Hospital Anxiety and Depression Scale)6 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 14, 2026